A detailed history of Nea Management Company, LLC transactions in Inventiva S.A. stock. As of the latest transaction made, Nea Management Company, LLC holds 1,462,586 shares of IVA stock, worth $3.83 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
1,462,586
Previous 1,462,586 -0.0%
Holding current value
$3.83 Million
Previous $4.37 Million 37.46%
% of portfolio
0.21%
Previous 0.41%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023

SELL
$3.66 - $7.05 $15 Million - $29 Million
-4,110,367 Reduced 73.76%
1,462,586 $6.52 Million
Q2 2022

Aug 15, 2022

BUY
$5.61 - $12.15 $24 Million - $51.9 Million
4,274,253 Added 329.12%
5,572,953 $31.6 Million
Q3 2021

Nov 12, 2021

BUY
$10.73 - $14.85 $2.76 Million - $3.82 Million
257,034 Added 24.68%
1,298,700 $18.4 Million
Q3 2020

Nov 06, 2020

BUY
$9.87 - $13.42 $10.3 Million - $14 Million
1,041,666 New
1,041,666 $12.3 Million

Others Institutions Holding IVA

About Inventiva S.A.


  • Ticker IVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,134,200
  • Market Cap $110M
  • Description
  • Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS), and other diseases. Its lead product candidate is Lanifibranor, which has completed Phase IIb clinical trial to treat NASH. The company als...
More about IVA
Track This Portfolio

Track Nea Management Company, LLC Portfolio

Follow Nea Management Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nea Management Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nea Management Company, LLC with notifications on news.